These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 34571078)
1. Updated evidence of Dengzhan Shengmai capsule against ischemic stroke: A systematic review and meta-analysis. Liu X; Li Y; Bai N; Yu C; Xiao Y; Li C; Liu Z J Ethnopharmacol; 2022 Jan; 283():114675. PubMed ID: 34571078 [TBL] [Abstract][Full Text] [Related]
2. Chinese herbal medicine Dengzhan Shengmai capsule as adjunctive treatment for ischemic stroke: A systematic review and meta-analysis of randomized clinical trials. Yang XY; Wang LQ; Li JG; Liang N; Wang Y; Liu JP Complement Ther Med; 2018 Feb; 36():82-89. PubMed ID: 29458937 [TBL] [Abstract][Full Text] [Related]
3. The add-on effect of dengzhan shengmai capsules on secondary prevention of ischemic stroke: A multicentre, randomised, placebo-controlled clinical trial. Cai Y; Zhang X; Huang Y; Wang L; Sun J; Liang W; Ou A; Yu B; Guo J; Zhao M; Ni X; Chen S Complement Ther Med; 2019 Oct; 46():189-194. PubMed ID: 31519277 [TBL] [Abstract][Full Text] [Related]
4. Single-cell RNA sequencing reveals that VIM and IFITM3 are vital targets of Dengzhan Shengmai capsule to protect against cerebral ischemic injury. Cao GZ; Hou JY; Zhou R; Tian LL; Wang ML; Zhang Y; Xu H; Yang HJ; Zhang JJ J Ethnopharmacol; 2023 Jul; 311():116439. PubMed ID: 37004745 [TBL] [Abstract][Full Text] [Related]
5. Multi-omics and network pharmacology study reveals the effects of Dengzhan Shengmai capsule against neuroinflammatory injury and thrombosis induced by ischemic stroke. Ye J; Huang F; Zeng H; Xu X; Wu G; Tian S; Zhao J; Zhang W J Ethnopharmacol; 2023 Apr; 305():116092. PubMed ID: 36587875 [TBL] [Abstract][Full Text] [Related]
6. Chinese herbal medicine Dengzhan Xixin injection for acute ischemic stroke: A systematic review and meta-analysis of randomised controlled trials. Li JG; Wang LQ; Yang XY; Chen Z; Lai LYW; Xu H; Liu JP Complement Ther Med; 2017 Oct; 34():74-85. PubMed ID: 28917378 [TBL] [Abstract][Full Text] [Related]
7. Dengzhan Shengmai capsule versus Aspirin in the treatment of carotid atherosclerotic plaque: A single-centre, non-inferiority, prospective, randomised controlled trial. Shen X; Zou S; Jin J; Liu Y; Wu J; Qu L Phytomedicine; 2022 Nov; 106():154408. PubMed ID: 36029646 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic understanding of the effect of Dengzhan Shengmai capsule on the pharmacokinetics of clopidogrel in rats. Chen X; Zhao Z; Chen Y; Gou X; Zhou Z; Zhong G; Cai Y; Huang M; Jin J J Ethnopharmacol; 2016 Nov; 192():362-369. PubMed ID: 27459888 [TBL] [Abstract][Full Text] [Related]
9. 4,5 caffeoylquinic acid and scutellarin, identified by integrated metabolomics and proteomics approach as the active ingredients of Dengzhan Shengmai, act against chronic cerebral hypoperfusion by regulating glutamatergic and GABAergic synapses. Sheng N; Zheng H; Li M; Li M; Wang Z; Peng Y; Yu H; Zhang J Pharmacol Res; 2020 Feb; 152():104636. PubMed ID: 31926275 [TBL] [Abstract][Full Text] [Related]
10. [Post-marketed re-evaluation of fleabane injection and Dengzhan Shengmai capsule study on treatment in patients with ischemic stroke]. Wei X; Ye X; Xie Y; Zou Y; Zhao X; Han J; Wang X; Ma Y; Bi Q; Xie Q; Zhao J; Cao X; Chen H; Wang S; Yan R; Han Z; Yi D; Wang Y Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2789-92. PubMed ID: 22292366 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Traditional Chinese Medicine in the Long-Term Secondary Prevention for Patients with Ischemic Stroke: A Systematical Analysis. Li J; Zhao X; Zhang Y; Wan H; He Y; Li X; Yu L; Jin W Front Pharmacol; 2021; 12():722975. PubMed ID: 34867326 [No Abstract] [Full Text] [Related]
12. Effectiveness and safety of Wuling capsule for post stroke depression: a systematic review. Peng L; Zhang X; Kang DY; Liu XT; Hong Q Complement Ther Med; 2014 Jun; 22(3):549-66. PubMed ID: 24906594 [TBL] [Abstract][Full Text] [Related]
13. Ginkgol Biloba extract as an adjunctive treatment for ischemic stroke: A systematic review and meta-analysis of randomized clinical trials. Ji H; Zhou X; Wei W; Wu W; Yao S Medicine (Baltimore); 2020 Jan; 99(2):e18568. PubMed ID: 31914035 [TBL] [Abstract][Full Text] [Related]
14. Xiaoxuming decoction for acute ischemic stroke: a systematic review and meta-analysis. Fu DL; Lu L; Zhu W; Li JH; Li HQ; Liu AJ; Xie C; Zheng GQ J Ethnopharmacol; 2013 Jun; 148(1):1-13. PubMed ID: 23583540 [TBL] [Abstract][Full Text] [Related]
15. Citicoline for treating people with acute ischemic stroke. Martí-Carvajal AJ; Valli C; Martí-Amarista CE; Solà I; Martí-Fàbregas J; Bonfill Cosp X Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013066. PubMed ID: 32860632 [TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of Xihuang Pill/capsule in adjuvant treatment of breast cancer: A systematic review and meta-analysis of 26 randomized controlled trials. Ge A; Yang K; Deng X; Zhao D; Ge J; Liu L J Ethnopharmacol; 2022 Sep; 295():115357. PubMed ID: 35545184 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Zhilong Huoxue Tongyu capsule in the treatment of acute cerebral infarction: A systematic review and meta-analysis of randomized controlled trials. Liu M; Pu Y; Gu J; He Q; Liu Y; Zeng Y; Li J; Long X; Yang S; Wu Q; Zhou H Phytomedicine; 2021 Jun; 86():153566. PubMed ID: 33940333 [TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of the Xuesaitong soft capsule in the treatment of patients with ischemic stroke: systematic review and meta-analysis. Gao Y; Chen Z; Li X; Cai Y; Gao F; Tang Y; Ran W Ann Palliat Med; 2022 Aug; 11(8):2695-2708. PubMed ID: 36064360 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of the Chinese herbal medicine Xiao-qing-long-tang for allergic rhinitis: A systematic review and meta-analysis of randomized controlled trials. Yan Y; Zhang J; Liu H; Lin Z; Luo Q; Li Y; Ruan Y; Zhou S J Ethnopharmacol; 2022 Oct; 297():115169. PubMed ID: 35257842 [TBL] [Abstract][Full Text] [Related]
20. Updated evidence of the Naoshuantong capsule against ischemic stroke: a systematic review and meta-analysis of randomized controlled trials. Que C; Wei Y; Yin G; Zhou C; Liu Z; Lai X; Qin M; Xiong X; Zheng X; Dong X; Gao Y Front Pharmacol; 2024; 15():1434764. PubMed ID: 39391695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]